Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Gross Profit: 2020-2024

Historic Gross Profit for LifeStance Health (LFST) over the last 5 years, with Q3 2024 value amounting to $100.4 million.

  • LifeStance Health's Gross Profit rose 3178.36% to $100.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $376.3 million, marking a year-over-year increase of 3368.09%. This contributed to the annual value of $302.1 million for FY2023, which is 2745.75% up from last year.
  • LifeStance Health's Gross Profit amounted to $100.4 million in Q3 2024, which was up 3178.36% from $97.8 million recorded in Q2 2024.
  • In the past 5 years, LifeStance Health's Gross Profit registered a high of $100.4 million during Q3 2024, and its lowest value of $14.2 million during Q2 2020.
  • In the last 5 years, LifeStance Health's Gross Profit had a median value of $60.3 million in 2022 and averaged $63.6 million.
  • As far as peak fluctuations go, LifeStance Health's Gross Profit soared by 26117.93% in 2021, and later surged by 1556.13% in 2022.
  • LifeStance Health's Gross Profit (Quarter) stood at $33.1 million in 2020, then surged by 63.72% to $54.2 million in 2021, then grew by 15.56% to $62.7 million in 2022, then soared by 32.89% to $83.3 million in 2023, then increased by 20.55% to $100.4 million in 2024.
  • Its Gross Profit was $100.4 million in Q3 2024, compared to $97.8 million in Q2 2024 and $94.7 million in Q1 2024.